International Vaccine Institute

Seoul, Korea, Republic of


Purpose

to enable the uptake of ALVAC vCP2438 and gp120 TV1/1086C prime boost HIV vaccine if it is found to have >50% efficacy at 3 years

Division

Global Health

Date

June 2019

Region Served

AFRICA

Committed amount

$262,377

Grant topic

HIV

Duration (months)

12

Grantee location

Seoul, Korea, Republic of

Related work

HIV

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.